Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins. They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury, e.g. after myocardial infarction, and in progression of diseases such as atheroma, arthritis, cancer and chronic tissue ulcers. They are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs). This review introduces the members of the MMP family and discusses their domain structure and function, proenyme activation, the mechanism of inhibition by TIMPs and their significance in physiology and pathology.

Original publication

DOI

10.1016/j.cardiores.2005.12.002

Type

Journal article

Journal

Cardiovasc res

Publication Date

15/02/2006

Volume

69

Pages

562 - 573

Keywords

Animals, Cardiovascular Diseases, Cardiovascular System, Extracellular Matrix, Humans, Matrix Metalloproteinase Inhibitors, Matrix Metalloproteinases, Structure-Activity Relationship, Tissue Inhibitor of Metalloproteinases